Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice

Biochemical and Biophysical Research Communications

Volumn 384, Issue 1, 2009, Pages 93-99

  Ko, Kerry W S ^a   Corry, David B ^a   Brayton, Cory F ^a   Paul, Antoni ^a   Chan, Lawrence ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Dermatitis; Inflammation; Lung disease; Peritonitis

Indexed keywords

ANTIGEN; APOLIPOPROTEIN E; ASPERGILLUS FUMIGATUS ANTIGEN; CHOLESTEROL; CROTON OIL; IMMUNOGLOBULIN E; INTERLEUKIN 6; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTERY; ARTICLE; CARDIOVASCULAR RISK; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; EOSINOPHIL; EXPERIMENTAL MODEL; FEMALE; LUNG DISEASE; MORPHOMETRICS; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; SKIN INFLAMMATION; SKIN ULCER;

ANIMALS; ANTIGENS, FUNGAL; APOLIPOPROTEINS E; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ATHEROSCLEROSIS; DERMATITIS; MICE; MICE, KNOCKOUT; PERITONITIS;

ASPERGILLUS FUMIGATUS; MUS;

EID: 65549139620     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.083     Document Type: Article

References (37)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C.J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y., and for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
2. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., and Lusis A.J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91 (1995) 2488-2496
3. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) II2-II10
4. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
5. Kiechl S., Egger G., Mayr M., Wiedermann C.J., Bonora E., Oberhollenzer F., Muggeo M., Xu Q., Wick G., Poewe W., and Willeit J. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103 (2001) 1064-1070
6. Meier C.R., Jick S.S., Derby L.E., Vasilakis C., and Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 351 (1998) 1467-1471
7. Paquette D.W. The periodontal infection-systemic disease link: a review of the truth or myth. J. Int. Acad. Periodontol. 4 (2002) 101-109
8. Naz S.M., and Symmons D.P. Mortality in established rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 21 (2007) 871-883
9. Solomon D.H., Goodson N.J., Katz J.N., Weinblatt M.E., Avorn J., Setoguchi S., Canning C., and Schneeweiss S. Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis. 65 (2006) 1608-1612
10. Kao A.H., Sabatine J.M., and Manzi S. Update on vascular disease in systemic lupus erythematosus. Curr. Opin. Rheumatol. 15 (2003) 519-527
11. Hahn B.H., Grossman J., Chen W., and McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J. Autoimmun. 28 (2007) 69-75
12. Bruce I.N. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44 (2005) 1492-1502
13. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
14. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347 (2002) 1557-1565
15. Steptoe A., Shamaei-Tousi A., Gylfe A., Henderson B., Bergstrom S., and Marmot M. Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart 93 (2007) 1567-1570
16. Haque S., Mirjafari H., and Bruce I.N. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Curr. Opin. Lipidol. 19 (2008) 338-343
17. Muhlestein J.B., and Anderson J.L. Infectious serology and atherosclerosis: how burdensome is the risk?. Circulation 107 (2003) 220-222
18. Roman M.J., Devereux R.B., Schwartz J.E., Lockshin M.D., Paget S.A., Davis A., Crow M.K., Sammaritano L., Levine D.M., Shankar B.A., Moeller E., and Salmon J.E. Arterial stiffness in chronic inflammatory diseases. Hypertension 46 (2005) 194-199
19. Datta D., Ferrell W.R., Sturrock R.D., Jadhav S.T., and Sattar N. Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis 192 (2007) 391-395
20. Breslow J.L. Mouse models of atherosclerosis. Science 272 (1996) 685-688
21. Aprahamian T., Rifkin I., Bonegio R., Hugel B., Freyssinet J.M., Sato K., Castellot Jr. J.J., and Walsh K. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J. Exp. Med. 199 (2004) 1121-1131
22. Stanic A.K., Stein C.M., Morgan A.C., Fazio S., Linton M.F., Wakeland E.K., Olsen N.J., and Major A.S. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 103 (2006) 7018-7023
23. -/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J. Lipid Res. 48 (2007) 794-805
24. Ma Z., Choudhury A., Kang S.A., Monestier M., Cohen P.L., and Eisenberg R.A. Accelerated atherosclerosis in ApoE deficient lupus mouse models. Clin. Immunol. 127 (2008) 168-175
25. Meir K.S., and Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1006-1014
26. Berg D.J., Leach M.W., Kuhn R., Rajewsky K., Muller W., Davidson N.J., and Rennick D. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J. Exp. Med. 182 (1995) 99-108
27. Mizgerd J.P., Bullard D.C., Hicks M.J., Beaudet A.L., and Doerschuk C.M. Chronic inflammatory disease alters adhesion molecule requirements for acute neutrophil emigration in mouse skin. J. Immunol. 162 (1999) 5444-5448
28. Grunig G., Corry D.B., Leach M.W., Seymour B.W., Kurup V.P., and Rennick D.M. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185 (1997) 1089-1099
29. Corry D.B., Grunig G., Hadeiba H., Kurup V.P., Warnock M.L., Sheppard D., Rennick D.M., and Locksley R.M. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol. Med. 4 (1998) 344-355
30. Murali P.S., Kumar A., Choi H., Banasal N.K., Fink J.N., and Kurup V.P. Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody. J. Leukoc. Biol. 53 (1993) 264-267
31. Guevara N.V., Kim H.S., Antonova E.I., and Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat. Med. 5 (1999) 335-339
32. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14 (1994) 133-140
33. Esdaile J.M., Abrahamowicz M., Grodzicky T., Li Y., Panaritis C., du B.R., Cote R., Grover S.A., Fortin P.R., Clarke A.E., and Senecal J.L. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 44 (2001) 2331-2337
34. del I R., Williams K., Stern M.P., Freeman G.L., and Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 44 (2001) 2737-2745
35. Bacon P.A., Stevens R.J., Carruthers D.M., Young S.P., and Kitas G.D. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun. Rev. 1 (2002) 338-347
36. Guillevin L., and Dorner T. Vasculitis: mechanisms involved and clinical manifestations. Arthritis Res. Ther. 9 Suppl. 2 (2007) S9
37. Frostegard J., Svenungsson E., Wu R., Gunnarsson I., Lundberg I.E., Klareskog L., Horkko S., and Witztum J.L. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 52 (2005) 192-200